Nicox annonce l’appr
Nicox annonce l’approbation de ZERVIATE en Chine
September 18, 2024 01:30 ET | NICOX SA
Communiqué de presseNicox annonce l’approbation de ZERVIATE en Chine Ocumension Therapeutics, partenaire licencié de Nicox, a reçu l'approbation de la demande d'autorisation de mise sur le marché en...
Nicox Announces Appr
Nicox Announces Approval of ZERVIATE in China
September 18, 2024 01:30 ET | NICOX SA
Press Release Nicox Announces Approval of ZERVIATE in China Nicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ocular itching in China ZERVIATE® launch in China will...
FLEX-O SIGNE UNE TROISIÈME IMPLANTATION DANS LA CAPITALE AVEC FLEX-O PARIS HAUSSMANN
September 11, 2024 11:29 ET | GROUPE COURTIN
Après avoir annoncé son implantation au 47 rue de Monceau et au 42-44 rue de Rome, FLEX-O annonce sa 3e implantation à Paris avec « FLEX-O PARIS HAUSSMANN», une adresse prestigieuse située au 69...
555.png
PlusInvesting Launches New Feature to Enhance Trading Efficiency for Canadian Users
September 09, 2024 07:29 ET | PlusInvesting
London,UK , Sept. 09, 2024 (GLOBE NEWSWIRE) -- PlusInvesting, a leading platform in the cryptocurrency trading industry, is proud to announce the launch of its latest feature designed to further...
Nasdaq.jpg.prdesk.globenewswire.jpg
Nasdaq Halts BAIYU Holdings, Inc.
September 06, 2024 11:04 ET | Nasdaq, Inc.
NEW YORK, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted on September 5, 2024 in BAIYU Holdings, Inc. (Nasdaq: BYU) at 19:50:00 Eastern...
DMR Logo.png
Next Generation Sequencing Market is Anticipated to Attain USD 92.2 Billion in Revenue by 2033 , at a CAGR 23.8%: Insights by Dimension Market Research
September 04, 2024 11:36 ET | Dimension Market Research
New York, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Overview The Global Next Generation Sequencing Market size is expected to reach USD 13.5 billion by 2024 and it is further anticipated to reach a...
GoodFirms
66.2% of the Survey Respondents Believe M&A Deals Can Boost the Market Share: GoodFirms Research
September 04, 2024 09:30 ET | GoodFirms
Washington, Sept. 04, 2024 (GLOBE NEWSWIRE) -- GoodFirms, a universally renowned B2B ratings and reviews platform, released its recent survey research report, "The impact of mergers and...
logo-alx-oncology-apr18-color.jpg
ALX Oncology Announces First Patients Dosed with Evorpacept and Sarclisa As Part of Randomized Phase 1/2 UMBRELLA Study with Sanofi
September 04, 2024 08:00 ET | ALX Oncology
SOUTH SAN FRANCISCO, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that...
Nicox nomme Christin
Nicox nomme Christine Placet administrateur ; Michele Garufi se retire du Conseil d’administration
September 04, 2024 01:30 ET | NICOX SA
Communiqué de presseNicox nomme Christine Placet administrateur ; Michele Garufi se retire du Conseil d’administration Christine Placet est Directrice Financière chez Theranexus, et a été...
Nicox Appoints Chris
Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board
September 04, 2024 01:30 ET | NICOX SA
Press Release Nicox Appoints Christine Placet to Board of Directors; Michele Garufi steps down from Board Christine Placet is CFO of Theranexus, and was formerly CEO of Horama and TrophosMichele...